Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Blue Sky Uranium Expands Drill Plan to Advance the Ivana Uranium-Vanadium Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Agilent Technologies Inc
A
Technology
Scientific & Technical Instruments
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of...
activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NYSE:A)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 02, 2024 3:11pm
Agilent Technologies, Inc. (NYSE:A): A Leader in Life Scienc
https://beyondspx.com/2024/07/31/agilent-technologies-inc-nysea-a-leader-in-life-sciences-and-diagnostics-poised-for-long-term-growth/
(59)
•••
Nibinator
X
Post by
Nibinator
on Oct 28, 2023 5:15pm
Real stock price share value
42$
(0)
•••
robertsmith02
X
Post by
robertsmith02
on Aug 29, 2022 4:57am
Global Metabolomics Market to Grow at 12% CAGR by 2027
The latest research study "Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" by IMARC Group, finds that the global metabolomics
...more
(1)
•••
edwardebreen15
X
Post by
edwardebreen15
on Aug 18, 2022 2:16am
Oligonucleotide Synthesis Market Analysis & Forecast 2022-27
According to IMARC Group’s latest report, titled “Oligonucleotide Synthesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global oligonucleotide
...more
(1)
•••
edwardebreen15
X
Post by
edwardebreen15
on Aug 16, 2022 2:02am
Forensic Technologies Market Analysis and Forecast 2022-2027
According to IMARC Group’s latest report, titled “Forensic Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global forensic technologies
...more
(13075)
•••
SusanBolland
X
Comment by
SusanBolland
on Feb 04, 2022 6:51am
RE:🎉📣FSD Pharma's Research and Clinical Advisory Board📢
(28)
•••
anjz661
X
Comment by
anjz661
on Jan 30, 2022 2:20pm
RE:RE:🎉📣FSD Pharma's Research and Clinical Advisory Board📢
Wow, that was a good bounce back week. Wouldn't mind another one like that.
(9875)
•••
Lisagerrard17
X
Comment by
Lisagerrard17
on Jan 18, 2022 1:54pm
RE:RE:Goto and rise
(13075)
•••
SusanBolland
X
Comment by
SusanBolland
on Jan 14, 2022 6:37am
RE:RE:Goto and rise
(13075)
•••
SusanBolland
X
Comment by
SusanBolland
on Jan 03, 2022 3:59pm
RE:🎉📣FSD Pharma's Research and Clinical Advisory Board📢
(13075)
•••
SusanBolland
X
Comment by
SusanBolland
on Dec 29, 2021 6:07am
RE:RE:Goto and rise
(13075)
•••
SusanBolland
X
Comment by
SusanBolland
on Dec 21, 2021 3:08pm
RE:🎥📰Anthony Durkacz on Building a Turnaround at FSD Pharma📣
(9750)
•••
Karren411
X
Comment by
Karren411
on Nov 21, 2021 2:12pm
RE:🎉📣FSD Pharma's Research and Clinical Advisory Board📢
(0)
•••
Janine56
X
Post by
Janine56
on Nov 19, 2021 1:19am
🎥📰Anthony Durkacz on Building a Turnaround at FSD Pharma📣
(0)
•••
Janine56
X
Post by
Janine56
on Nov 17, 2021 11:12pm
🎉📣FSD Pharma's Research and Clinical Advisory Board📢
Dr. Eleanor N. Fish, a world-renowned immunologist and cytokine expert, has been appointed to FSD Pharma's Research and Clinical Advisory Board. FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Largest integrated facility services provider in Canada releases financial results for Q1, 2025
Healthcare and Clinical Stage Drug Development Company Acquires NoBrainer Imaging Centers
This company is set to benefit from a change in Ontario legislation
How Web3 Will Fundamentally Reshape Finance